Ataxxa 2000 mg/400 mg spot-on solution for dogs over 25 kg

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Permethrin; Imidacloprid

から入手可能:

Krka, d.d., Novo mesto

ATCコード:

QP53AC54

INN（国際名）:

Permethrin; Imidacloprid

投薬量:

2000, 400 mg/pipette

医薬品形態:

Spot-on solution

処方タイプ:

POM: Prescription Only Medicine as defined in relevant national legislation

治療群:

Dogs

治療領域:

permethrin, combinations

適応症:

Ectoparasiticide

認証ステータス:

Authorised

承認日:

2015-10-30

製品の特徴

ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
CONFIDENTIAL
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ataxxa 2000 mg/400 mg spot-on solution for dogs over 25 kg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.0 ml pipette contains:
ACTIVE SUBSTANCES:
Permethrin 2000.0 mg
Imidacloprid 400.0 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE COMPOSITION IF THAT
INFORMATION IS ESSENTIAL FOR PROPER
ADMINISTRATION OF THE VETERINARY MEDICINAL
PRODUCt
Butylhydroxytoluene (E321)
4.0 mg
Triglycerides, Medium-Chain
N-methylpyrrolidone
800.0 mg
Citric acid (E330)
Dimethyl sulfoxide
Clear yellowish to brownish spot on solution
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the treatment and prevention of flea (_Ctenocephalides felis_)
infestation.
Fleas on dogs are killed within one day following treatment. One
treatment prevents further
flea infestation for four weeks. The veterinary medicinal product can
be used as part of a
treatment strategy for flea allergy dermatitis (FAD).
The veterinary medicinal product has persistent acaricidal efficacy
against tick infestations
(_Rhipicephalus sanguineus_ and _Ixodes ricinus _ for four weeks, and
_Dermacentor reticulatus _
for three weeks) and persistent repellent efficacy (_Ixodes ricinus_)
for three weeks.
Ticks already on the dog may not be killed within two days after
treatment and may remain
attached and visible. Therefore the removal of ticks already on the
dog at the time of
treatment is recommended, in order to prevent them from attaching and
having a blood meal.
One treatment provides repellent (anti-feeding) activity against the
sand fly_ Phlebotomus _
_perniciosus_ for three weeks and against the mosquito _Aedes aegypti_
from 7 days up to 14 days
after treatment.
CONFIDENTIAL
Reduction of the risk of infection with _Leishmania infantum_ via
transmission by sandflies
(_Phlebotomus perniciosus_) for up to 3 weeks. The effect is indirect
due to the veterinary
medicinal product's act